搜索临床试验以:吉西他滨、多西紫杉醇和卡培他滨
总计6567个结果
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
ImmunityBio, Inc.完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Sarcoma Alliance for Research through Collaboration完全的
-
Spanish Lung Cancer GroupAventis Pharmaceuticals完全的
-
Shanghai Yizhong Pharmaceutical Co., Ltd.招聘中
-
Federation Francophone de Cancerologie Digestive招聘中
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
Mario Negri Institute for Pharmacological ResearchPharmaMar完全的
-
Karolinska University Hospital未知
-
Latin American Cooperative Oncology GroupGlaxoSmithKline完全的管理系统1 | 开始研究的绩效状态为零到二 | 接受最多一次化疗的患者 | 紫杉烷类药物后进展的患者阿根廷, 巴西, 秘鲁
-
Cyclacel Pharmaceuticals, Inc.完全的
-
Asan Medical CenterSeoul St. Mary's Hospital; Severance Hospital; Bundang CHA Hospital完全的
-
Fudan UniversityNanfang Hospital of Southern Medical University; Ningbo Medical Center Lihuili Hospital; Shenzhen... 和其他合作者招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)终止
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Yonsei University完全的
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.完全的
-
Japan Multinational Trial Organization完全的
-
Zhejiang Cancer Hospital招聘中胃癌 | 大肠癌 | 胰腺癌 | 胆道癌 | 胃食管结合部腺癌 | 肝癌第四期中国
-
Cyteir Therapeutics, Inc.主动,不招人软组织肉瘤 | 滤泡性淋巴瘤 | 乳腺癌 | 头颈癌 | 小细胞肺癌 | 多发性骨髓瘤 | 胰腺癌 | 卵巢癌 | 套细胞淋巴瘤 | 头颈部鳞状细胞癌 | 三阴性乳腺癌 | DLBCL | 非霍奇金淋巴瘤 | 恶性肿瘤 | 慢性淋巴细胞白血病美国
-
Nathan Pennell, MD, PhDNational Cancer Institute (NCI)完全的
-
University of Alabama at BirminghamNational Cancer Institute (NCI)完全的
-
China Association of Osteosarcoma Chemotherapy未知洛铂和吉西他滨联合治疗晚期骨肉瘤的二线治疗
-
Eye & ENT Hospital of Fudan UniversityShandong Provincial Hospital; Harbin Medical University Third Affiliated Hospital招聘中